Lapatinib Completed Phase 1 Trials for Colorectal Cancers / Head and Neck Carcinoma / Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01184482Lapatinib and Cetuximab in Patients With Solid Tumors